Envision Pharma Group kick off 2020 by scooping a triple win at the PM Society Awards
The PM Society Awards 2020 saw Envision pick up a gold award for Events and Exhibitions, along with two silver accolades for Interactive Communications and Innovations relating to its work in collaboration with Mundipharma.
Envision’s Mundipharma account team were joined by members of the pharma company on January 24 at The Grosvenor House in London to accept the outcome from the event judges, which even included a new category win for interactive communications.
Comments from the judges relating to the gold award noted, “It was a brave client who agreed not to show their data until delegates interacted with it, but it paid off.”
Multichannel Director at Envision Alex Watson added, “What a fantastic way for us to start the year with a triple win at the 2020 PM Society Awards. To make a real difference we believe you sometimes have to look at things from a different perspective.
“Congratulations to our exceptionally talented creative team who, in close partnership with Mundipharma and supported by woolley pau gyro, conceptualized and created this exemplar of MedComms lateral thinking that had a very real impact in getting this important message across.”
The PM Society Awards recognize creativity, impact, and innovation within communications activities in the pharmaceutical, biotechnology, and healthcare industries. The awards are unique among creative healthcare awards, in that they include categories judged by healthcare professionals – the targets of the work – as well as those judged by agency creatives and marketers.
Watson noted, “This is the second successive year that Envision has entered and won at the PM Society Awards. To have achieved this here two years in a row is testament to the talents and capabilities of our in-house team.”
About the Mundipharma Network
Mundipharma is a global network of privately-owned independent associated companies whose purpose is to move medicine forward. With a high performing and learning organisation that strives for innovation and commercial excellence through partnerships, we successfully transformed and diversified our European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as Diabetes, Respiratory, Oncology, Pain and Biosimilars.
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving the pharmaceutical, biotechnology, and medical device industries. Envision is a leading provider of evidence-based communication services and industry leading technology solutions that have applicability across many areas of medical affairs and related functional responsibilities. Envision Pharma Group provides services and technology solutions to more than 90 companies, including 19 of the top 20 pharmaceutical companies.
Envision has twelve offices, four in the United Kingdom – Bishop’s Stortford, Horsham, London, and Wilmslow; one in Serbia; one in Hungary; four in the United States – Philadelphia, PA; Warren, NJ; Fairfield and Glastonbury, CT; and two in the Asia Pacific region – Tokyo and Sydney. The company employs more than 730 team members, including more than 250 highly qualified and experienced in-house medical writers and 140 technology solutions team members who provide software development and customer support.